new glp-1 drug retatrutide “Let’s talk — the newest multi-agonist making waves in metabolic medicine. This next-gen medication targets not one, not two, but three key receptors: GLP-1, GIP, and glucagon. The result? New GLP-3 drug significantly slashes

Individual results vary significantly based on medication adherence, dosage, diet, exercise, genetics, baseline health, and other factors

report a decreased risk of RGC in patients on GLP-1 RAs undergoing concurrent EGD and colonoscopy when compared to EGD alone (protection ratio (PR) = 0.25, confidence interval 0.160.39) [16]

Ultra-Processed Foods Processed foods and high-sugar items are both enemies of our health

Although this also may come with age as the body loses neurons that are responsible for storing memory and a process that cannot be reversed

Came with everything I needed

151 genetic insights 49 unique peptides 57 SNPs 48 genes 14 health pathways